As the science stands, the vast majority of the roughly eight million people in South Africa living with HIV will have to get ...
A Hong Kong biotech company said its therapeutic HIV vaccine showed “promising” results in a recent clinical trial, taking it ...
Code Pharma today announced positive eight-week results for human immunodeficiency virus (HIV)-drug Gammora®, showing ...
HONG KONG SAR - Media OutReach Newswire – 12 November 2024 - Immuno Cure BioTech (" Immuno Cure "), a clinical-stage ...
Immuno Cure is a clinical stage biotechnology group based in the Hong Kong Science Park, focusing on research and development ...
From Bettina Bauer, Vice President, US HIV Treatment and Prevention, Gilead Sciences In 2022, there were up to 1.2 million ...
A virologist at the University of Nebraska-Lincoln, Qingsheng Li, was awarded $3.5 million to advance his work on a vaccine ...
Our HIV epidemic is one of the fastest growing in the world. While there have been many improvements in access to care and life-saving treatment, it cannot be business as usual since more and more ...
The Ochsner Transplant Institute served as one of 26 U.S. transplant centers collaborating in an HIV-to-HIV kidney transplant study ...
Proof-of-Concept Study to Find Functional Cure for HIV July 24, 2024 — Researchers conducted a breakthrough proof-of-concept study that found an HIV-like virus particle that could cease the need ...